Mansoor M. Amiji

发表

CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood–Brain Barrier and Towards Specific Cellular Targeting

A. D'Souza, B. Bleier, Saeideh Nozohouri, 2022, Pharmaceutical Research.

Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils.

Daniel A. Skelly, M. Wiles, L. Shultz, 2020, Drug discovery today.

Cold exposure impairs extracellular vesicle swarm-mediated nasal antiviral immunity.

Maie S. Taha, A. Workman, B. Bleier, 2022, The Journal of allergy and clinical immunology.

Overview of vaccine adjuvants

D. O'hagan, Mansoor M Amiji, Rushit N. Lodaya, 2022, Practical Aspects of Vaccine Development.

Local and systemic delivery strategies for glioma immunotherapy

N. Parayath, L. Milane, Mansoor M Amiji, 2022 .

Cellular therapeutics in immuno-oncology

Mansoor M Amiji, Gulzar Ahmad, Mansoor M. Amiji, 2022 .

Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets.

P. Kulkarni, C. Ferris, B. Bleier, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Tumor-targeted miRNA nanomedicine for overcoming challenges in immunity and therapeutic resistance.

Srujan Gandham, N. Parayath, Mansoor M Amiji, 2022, Nanomedicine.

Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine.

S. Bertholet, S. Nuti, D. O'hagan, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of the Factors Influencing Stomach‐specific Delivery of Antibacterial Agents for Helicobacter pylori Infection

R. Qaqish, V. Patel, Sweta Shah, 1999, The Journal of pharmacy and pharmacology.

Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models

M. Wiles, J. Bubier, L. Shultz, 2021, Cells.

Expanding CRISPR repertoire using CjCas9 as a smaller editing tool

Mansoor M. Amiji, Christopher Francis, 2022, Molecular therapy. Nucleic acids.

Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide

L. Milane, Aishwarya Ganesh, H. Hussain, 2023, Expert opinion on drug delivery.

Cholesterol-Conjugated Short-Interfering RNA Silencing Tnf for the Treatment of Liver Macrophage-Mediated Acute Inflammation in Nonalcoholic Fatty Liver Disease.

M. Abrams, Mansoor M Amiji, Kevin P. Craig, 2022, Nucleic acid therapeutics.

Recent preclinical and clinical advances in oligonucleotide conjugates

M. Abrams, Kevin P Craig, Mansoor M Amiji, 2018, Expert opinion on drug delivery.

Bacterial extracellular vesicle applications in cancer immunotherapy

A. D'Souza, Mansoor M Amiji, Di Huang, 2022, Bioactive materials.

Hepatocyte-specific gene editing with HA nanoparticles.

Liliana Wroblewska, P. Pegman, Mansoor M. Amiji, 2021, Nanomedicine : nanotechnology, biology, and medicine.

Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies.

A. D'Souza, N. Parayath, B. Bleier, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Role of 3D Printing in the Development of Biodegradable Implants for Central Nervous System Drug Delivery.

A. D'Souza, S. Kutlehria, B. Bleier, 2022, Molecular pharmaceutics.

Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines.

L. Milane, Mansoor M Amiji, S. Dolare, 2021, Nanomedicine : nanotechnology, biology, and medicine.

Long-Acting Therapeutic Delivery Systems for the Treatment of Gliomas.

Smrithi Padmakumar, Mansoor M. Amiji, 2023, Advanced drug delivery reviews.

Delivery of Oligonucleotide Therapeutics for Macrophage Reprogramming in Inflammatory Diseases

Dhaval Oza, Mansoor M. Amiji, 2022, Macrophage Targeted Delivery Systems.

Application of nanotechnology in medical diagnosis and imaging.

Amit Singh, Mansoor M. Amiji, 2022, Current opinion in biotechnology.

Mathematical Modeling and Experimental Validation of Extracellular Vesicle-Mediated Tumor Suppressor MicroRNA Delivery and Propagation in Ovarian Cancer Cells.

H. Attarwala, Srujan Gandham, Mansoor M. Amiji, 2022, Molecular pharmaceutics.

Nasal delivery of nanotherapeutics for CNS diseases: challenges and opportunities.

A. D'Souza, S. Kutlehria, B. Bleier, 2021, Nanomedicine.

Cystatin SN is a Potent Upstream Initiator of Epithelial Derived Type 2 Inflammation in Chronic Rhinosinusitis.

A. Workman, P. Sadow, B. Bleier, 2022, The Journal of allergy and clinical immunology.

Nanotechnology-enabled topical delivery of therapeutics in chronic rhinosinusitis.

B. Bleier, Mansoor M. Amiji, Di Huang, 2023, Nanomedicine.

Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for multidrug resistant breast cancer.

L. Milane, Mansoor M. Amiji, Saket Dolare, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Strategies to reduce the risks of mRNA drug and vaccine toxicity.

D. Bitounis, Mansoor M. Amiji, Eric Jacquinet, 2024, Nature reviews. Drug discovery.

RNA therapies for CNS diseases.

B. Bleier, Mansoor M. Amiji, Di Huang, 2024, Advanced drug delivery reviews.

Lipid nanoparticles target haematopoietic stem cells.

Mansoor M. Amiji, Dimitrios Bitounis, 2024, Nature Nanotechnology.

Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations

Maie S. Taha, A. D'Souza, S. Kutlehria, 2023, Molecular pharmaceutics.

CNS delivery of targeted protein degraders.

Mansoor M. Amiji, Prashant Agarwal, Darren L Reid, 2024, Journal of controlled release : official journal of the Controlled Release Society.

Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases

D. Chellappan, K. Paudel, Gabriele De Rubis, 2024, Journal of Drug Delivery Science and Technology.